Rational design and synthesis of highly potent β-glucocerebrosidase inhibitors

被引：92

作者：

Zhu, XX

Sheth, KA

Li, SH

Chang, HH

Fan, JQ

机构：

[1] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA

[2] Amicus Therapeut Inc, Cranbury, NJ 08512 USA

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2005年 / 44卷 / 45期

关键词：

biological activity; drug design; enzymes; inhibitors; natural products;

D O I：

10.1002/anie.200502662

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

(Chemical Equation Presented) Highly potent human β-glucocerebrosidase inhibitors have been synthesized that appear to recognize both carbohydrate and hydrophobic binding sites. The most potent inhibitor, 6-nonyl isofagomine (see formula), shows an IC50 value at subnanomolar concentrations. These compounds are potential candidates for the development of small-molecule drugs for the treatment of Gaucher disease. © 2005 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

收藏

页码：7450 / 7453

页数：4

相关论文

共 22 条

[11]

Fabrega Sylvie, 2002, Journal de la Societe de Biologie, V196, P151

[12] Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor [J].

Fan, JQ ;

Ishii, S ;

Asano, N ;

Suzuki, Y .

NATURE MEDICINE, 1999, 5 (01) :112-115

[13] A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity [J].

Fan, JQ .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (07) :355-360

[14]

GRABOWSKI GA, 1993, ADV HUM GENET, V21, P377

[15] 1-N-iminosugars:: Potent and selective inhibitors of β-glycosidases [J].

Ichikawa, Y ;

Igarashi, Y ;

Ichikawa, M ;

Suhara, Y .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (13) :3007-3018

[16] Iminosugars: Potential inhibitors of liver glycogen phosphorylase [J].

Jakobsen, P ;

Lundbeck, JM ;

Kristiansen, M ;

Breinholt, J ;

Demuth, H ;

Pawlas, J ;

Candela, MPT ;

Andersen, B ;

Westergaard, N ;

Lundgren, K ;

Asano, N .

BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) :733-744

[17] ISOFAGOMINE, A POTENT, NEW GLYCOSIDASE INHIBITOR [J].

JESPERSEN, TM ;

DONG, WL ;

SIERKS, MR ;

SKRYDSTRUP, T ;

LUNDT, I ;

BOLS, M .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1994, 33 (17) :1778-1779

[18] Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin [J].

Lillelund, VH ;

Jensen, HH ;

Liang, XF ;

Bols, M .

CHEMICAL REVIEWS, 2002, 102 (02) :515-553

[19] N-octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells:: a potential chemical chaperone therapy for Gaucher disease [J].

Lin, H ;

Sugimoto, Y ;

Ohsaki, Y ;

Ninomiya, H ;

Oka, A ;

Taniguchi, M ;

Ida, H ;

Eto, Y ;

Ogawa, S ;

Matsuzaki, Y ;

Sawa, M ;

Inoue, T ;

Higaki, K ;

Nanba, E ;

Ohno, K ;

Suzuki, Y .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2004, 1689 (03) :219-228

[20] Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins [J].

Mellor, HR ;

Nolan, J ;

Pickering, L ;

Wormald, MR ;

Platt, FM ;

Dwek, RA ;

Fleet, GWJ ;

Butters, TD .

BIOCHEMICAL JOURNAL, 2002, 366 :225-233